The largest database of trusted experimental protocols

5 protocols using recombinant human basic fgf

1

Maintenance and Passaging of Human Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
hESCs were used according to the hESC research guidelines of the Japanese government. For the experiments shown, we used the VA22-N37 cell line11 (link); however, for reproducibility, the results were confirmed using KhES-1 (KUIMSe001-A) and KhES-3 (KUIMSe003-A) cells (Fig. S4). VA22-N37 is a RAX::Venus reporter hESC line11 (link) established based on KhES-1 (KUIMSe001-A) and they are biological replicates. Undifferentiated hESCs were maintained on a feeder layer of mouse embryonic fibroblasts (MEFs) inactivated by mitomycin C treatment in DMEM/F12 (D6421/Sigma) supplemented with 20% (vol/vol) KSR (lot No. 1517496/Invitrogen), 0.1 mM non-essential amino acids (11140-050/Invitrogen), 2 mM L-glutamine, 5 ng/mL recombinant human basic FGF (068-04544/Wako), and 0.1 mM 2-mercaptoethanol under an atmosphere of 2% CO2. For passaging, hESC-colonies were detached and recovered en bloc from culture dishes by treating them with 0.25% (wt/vol) trypsin and 0.1 mg/mL collagenase IV in PBS containing 20% (vol/vol) KSR and 1 mM CaCl2 at 37 °C for 8 min. The detached hESC clumps were broken into smaller pieces by gentle pipetting. The passages were performed at a 1:5 split ratio. When we performed SFEBq culture, small broken pieces of hESC clumps were incubated on gelatin-coated plate for 90 minutes to eliminate MEFs (Fig. S5).
+ Open protocol
+ Expand
2

Culturing and Differentiating Osteosarcoma Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were obtained from the RIKEN Cell Bank (Saitama, Japan) and cultured in DMEM (FUJIFILM Wako Pure Chemical) supplemented with 10% FBS (Hyclone) and 1% penicillin/streptomycin (Thermo Fisher Scientific) at 37°C in 5% CO2 (42 (link)). The patient-derived OS cell line 143B was obtained from the ATCC (Manassas, USA) and cultured in adherent medium containing DMEM supplemented with 10% FBS, 110 μg/mL sodium pyruvate (FUJIFILM Wako Pure Chemical), and 1% penicillin/streptomycin. Both cell types were cultured in tissue culture dishes (SARSTEDT) to ensure optimal adherence and expansion. To enrich stem-like cells, 143B cells were harvested using trypsin (BD Bioscience) and EDTA (FUJIFILM Wako Pure Chemical), then cultured in osteosphere medium containing DMEM/F12 (FUJIFILM Wako Pure Chemical) supplemented with 20 ng/mL recombinant human EGF (FUJIFILM Wako Pure Chemical), 20 ng/mL recombinant human basic FGF (FUJIFILM Wako Pure Chemical), B27 supplement without vitamin A (Gibco), GlutaMAX (Thermo Fisher Scientific), and 1% penicillin/streptomycin. Under these conditions, the cells were incubated in Ultra-Low Attachment Surface culture dishes (Corning). To assess the differentiation potential of OSCs, the cells were transferred from osteosphere to adherent medium, and from Ultra-Low Attachment Surface to tissue culture dishes, to promote adherence and differentiation.
+ Open protocol
+ Expand
3

Employing Engineered Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used chicken B cell lymphoma cell line DT40. In addition, we used two DT40 cell lines containing one human chromosome 4 (DT40 + hCh4) or one mouse chromosome 11 (DT40 + mCh11), which were created via microcell-mediated cell fusion (Oshimura et al. 2015 (link)). Chicken DT40 cells were cultured in RPMI medium 1640 (Gibco®, Thermo Fisher Scientific, Waltham, MA, USA), 10% foetal bovine serum (FBS, Corning, NY, USA), 0.1% chicken serum, 0.1 mM β-mercaptoethanol (2ME, Sigma-Aldrich, St. Louis, MO, USA). Cells were grown under 5% CO2 at 39˚C. Mouse J1 ESCs were cultured on the feeder cells in DMEM F12 (Wako, Osaka, Japan) supplemented with 10% FBS, 0.1 mM nonessential amino acid and sodium pyruvate (Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, USA), penicillin–streptomycin and 2 mM l-glutamine (Gibco®), 0.1 mM 2ME, and 103 U/ml ESGRO® LIF (Merck, Kenilworth, NJ, USA). Feeder cells were mitomycin C-treated mouse embryonic fibroblasts (MEF) derived from embryonic day 12.5. Human female iPSCs (KAC, Kyoto, Japan) were cultured on feeder cells in DMEM F12 HAM (Wako) supplemented with 20% KnockOut Serum Replacement (KSR™, Thermo Fisher Scientific), 0.1 mM nonessential amino acid, 2 mM L-glutamine, 1 × penicillin–streptomycin, 0.1 mM 2ME, and 5 ng/ml recombinant human basic FGF (Wako). Mouse and human cells were grown under 5% CO2 at 37 °C.
+ Open protocol
+ Expand
4

Glioblastoma Stem Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells and HEK293GP cells were purchased from the RIKEN Cell Bank and Takara Bio, respectively. These cells were cultured at 37°C in a 5% CO2 incubator and maintained in DMEM supplemented with FBS. Human patient-derived GBM cell lines TGS-01 and TGS-04 were established as described previously (23 (link)). The use of these human materials and protocols were approved by the Ethics Committees of Gifu Pharmaceutical University (Gifu, Japan) and the University of Tokyo (Tokyo, Japan). These cells were confirmed as GSCs and cultured in neurosphere medium containing DMEM/F12 (FUJIFILM Wako Pure Chemical) supplemented with recombinant human EGF at 20 ng/mL (FUJIFILM Wako Pure Chemical), recombinant human basic FGF at 20 ng/mL (FUJIFILM Wako Pure Chemical), B27 supplement without vitamin A (Gibco), and GlutaMAX (Gibco).
+ Open protocol
+ Expand
5

Primed hiPSC Maintenance and Passaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
We prepared mouse embryonic fibroblasts (MEFs) (KBL9284600; Kitayama Labes, Nagano, Japan) inactivated by mitomycin C treatment on 0.1% gelatin-coated dishes (1.2 × 106 cells/10 cm dish). Mice were not directly involved in the study. Primed hiPSCs frozen in liquid nitrogen were thawed as quickly as possible in warmed maintenance medium, comprising DMEM/F12 (D6421; Sigma, St. Louis, Missouri, USA) supplemented with 20% (v/v) KSR (lot No. 1517496; Invitrogen, Waltham, Massachusetts, USA), 0.1 mM non-essential amino acids (11140-050; Gibco), 2 mM l-glutamine (25030-081; Gibco), 5 ng/mL recombinant human basic FGF (068-04544; Wako, Osaka, Japan), and 0.1 mM 2-mercaptoethanol (131-14572; Wako. Cells suspended in maintenance medium were distributed on MEF-coated dishes and maintained in a CO2 incubator under 2% CO2 at 37 °C. The medium was changed daily.
For passaging, primed hiPSC colonies were harvested by incubation in 0.25% (w/v) trypsin and 0.1 mg/mL collagenase IV in PBS containing 20% (v/v) KSR and 1 mM CaCl2 for 6–8 min at 37 °C. The harvested clumps were broken into smaller pieces by gentle pipetting. The passages were performed at a split ratio of 1:4–6.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!